INTRODUCTION
In 2009 a new product was launched claiming to be a revolutionary material capable of offering a bioactive and biocompatible replacement for dentine. The calcium-based cement is reported to preserve pulp vitality, promote pulp healing and provide a bioactive substitute for natural dentine. Its clinical indications are extensive (Table 1) being described as a restorative material suitable for use wherever dentine replacement is required. 1 The reported clinical advantages of this material include quick setting time, rapid development of mechanical strength, easy handling and minimal requirement for cavity preparation.
2, 3, 4 In a previous article 4 the physical, chemical, mechanical and biological properties of the material were discussed, including the preliminary results of in vitro and in vivo trials with this material. It is the purpose of this article to look at two clinical cases using this new material for endodontic purposes.
The endodontic indications of the novel material are similar to mineral trioxide aggregate (MTA), but are reported to offer several advantages including: was coronally restorable and served as a functional tooth in both occlusion and as an abutment for a removable partial denture. There were no clinical signs of endodontic infection.
Radiographic examination
Radiographic examination (of the referring clinician's radiograph) showed a peri-apical radiograph that was poorly paralleled (Fig. 1) . However, enough clinical information was present to see an endodontic file showing a perforation distally. A periapical radiolucency was also present on the 35.
• Presents two case reports using this cement for surgical endodontic purposes, identifying its advantages over currently used alternatives.
• Highlights the clinical handling properties of the novel cement.
• Discusses the value and future of the material in general dental practice. 
I N B R I E F

PRACTICE
Diagnosis and treatment planning
A diagnosis of chronic periapical periodontitis and distal iatrogenic perforation 35 was made. Treatment options for the 35 were discussed at length with the patient and the decision was made to restore the perforation and endodontically treat the 35. Following this a composite core would be placed followed by a metal ceramic crown.
Clinical procedure
Anaesthesia and rubber dam
Anaesthesia was achieved via a left hand side inferior dental nerve block and buccal infiltration adjacent to the 35. The MO amalgam in the 35 was removed under rubber dam.
Surgical endodontic perforation
The canal was identified, irrigated, dried with paper points and temporarily isolated with a cotton pledglet. The perforation was then directly observed under microscopic magnification. The distal perforation was larger than expected, measuring approximately 5 mm in height and 2 mm in width, and extended below the alveolar crest. Chemical irrigation of the perforation was performed and haemostasis achieved.
Correction of the perforation and root canal treatment
Biodentine™, packed with an amalgam plugger, was used to restore the defect. Routine endodontic treatment was then performed once the Biodentine™ had fully set.
Coronal Restoration
Coronally, the 35 was restored with a composite core and definitively with a metalceramic crown.
Review
The post-operative radiograph (Fig. 2) , prior to crown preparation, shows a very well adapted perforation repair. The area has been marked on the radiograph as it is difficult to visualise when using conventional radiographic films. The patient is completely pain free and the 35 is a functional tooth. The patient will have his six month endodontic review at the next appointment..
CLINICAL CASE STUDY TWO Presenting complaint
At the time of presentation, patient B, a 47-year-old female, reported recurrent gingival swellings and a continuous dull ache associated with the upper right central incisor (11) over the past three years. There was tenderness to buccal palpation over the apex (Fig. 3) . These symptoms had been ongoing following root canal treatment of the tooth.
Medical history and clinical examination
The patient is medically fit and well. She is a non-smoker and drinks alcohol on an occasional basis. The patient is a regular dental attendee and is dentally motivated. Extra-orally and tra-orally there were nil findings of relevance other than tenderness to buccal palpation.
Radiographic examination
Radiographic examination with a long cone periapical revealed a large periapical radiolucency associated with the upper right central incisor (Fig. 4 ).
Diagnosis and treatment planning
A diagnosis of chronic apical abscess was given for the 11. There was reason to believe that proper aseptic techniques may not have been followed at the time of the original root canal filling, and it was assumed possible that conventional orthograde re-root treatment may resolve the periapical infection as an initial measure. Throughout the conventional orthograde re-root canal treatment, however, there was continuous suppuration from the apex and an adequate apical seal could not be guaranteed. It was deemed necessary to therefore provide root resection and retrograde root filling for this tooth.
Clinical procedure
Anaesthesia
Anaesthesia was achieved through topical anaesthesia followed by high buccal and palatal infiltrations adjacent to 11.
Flap design
A 3-sided full thickness mucoperiosteal flap was raised to perform apical surgery on the 11.
Access and root resection
Access was gained to the surgical apical site through use of a straight handpiece and round bur, and enlarged with a fissure bur. Granulation tissue was removed at the site, followed by root end resection with the fissure bur of 2-3 mm.
Retrograde preparation and obturation of canal
The canal was observed and approximately 3 mm of gutta percha removed with an ultrasonic tip. Haemostasis was achieved and the canal dried with paper points. The retrograde cavity was then obturated with Biodentine™ and packed using an amalgam plugger. The excess cement was removed and the root end cleaned.
Flap replacement
The flap was replaced and secured with interrupted sutures. Post-operative instructions were given and a post-operative radiograph taken (Fig. 4) .
Review
The tooth was reviewed one week later for suture removal and will be reviewed six months later. At one week, the surgical site was healing well with no signs of a continuing periapical pathology, and resolution of the patient's symptoms.
CLINICAL OBSERVATIONS OF NOVEL MATERIAL
Manipulation and handling
The authors found the novel material easy to manipulate and handle within the intraoral environment. In particular, handling within the surgical sites was comparable to MTA. The consistency of the material was such that packing into the root end was straightforward.
Setting time
Following mixing, the material has an adequate working time to allow for placement and plugging of the retrograde root filling. Development of the final set appeared to occur after approximately 12 minutes.
Radiographic appearance
The radiographic appearance of the material is important in order to assess for an apical seal, or for recurrent caries in cases where the material is used coronally. It is reported the material is radio-opaque as a result of the addition of zirconium dioxide. 1 However, the post-op radiographs for patients A and B (Figs 2 and  4) show a faintly radiolucent appearance of the material which makes radiographic assessment of success difficult and an issue for short-and long-term follow up. ISO standard 6876:2012 governs the specific requirements for root canal sealing materials used via an orthograde approach. 7 It determines that root canal sealing materials should have a minimum radiopacity equivalent to 3.0 mm of aluminium. The manufacturers claim that the new material, with a radiopacity equivalent of 3.5 mm of aluminium, satisfactorily complies with this international standard. It would appear from these two cases, however, that compliance does not necessarily translate into an ideal clinical result when this material is used for retrograde endodontics. Unfortunately there is as yet no international standard for the minimum radiopacity for retrograde filling materials.
In a related study by 
Biocompatibility and bioactivity
For both cases treated with Biodentine™, there were no reported sensitivity type reactions or rejection of the material. As follow up of these patients is still ongoing and without histological analysis of the tissues in contact with the material, the purported biocompatible and bioactive properties of the material cannot be confirmed. Likewise without histological analysis of the teeth treated with this new material, it is difficult to assess whether there is evidence of its reported bioactivity.
Longevity
Through post-operative follow-up it is hoped the apical seal will be able to be reviewed radiographically to assess the material's longevity
CONCLUSION
The reported biocompatible and bioactive properties of this new material combined with its mechanical properties offers an attractive solution to a number of clinical scenarios, which may occur from anywhere in the crown down to the root apex. The case reports described have further illustrated the material to be clinically practical and user-friendly. 'However, the results of on-going clinical in vivo investigations, randomised control trials, case reports and further independent clinical trials with extended follow-up periods. So far the manufacturer's claims have largely been supported by in vitro investigations and if this can transfer into clinical practice the promise of a new generation of regenerative restorative material may be realised. 
